Clinical Trials Directory

Trials / Completed

CompletedNCT06136975

Low-level Laser Therapy for Genitourinary Syndromes and Stress Urinary Incontinence

The Efficacy of Low-level Laser Therapy in Relieving Vaginal Dryness and Lower Urinary Tract Symptoms

Status
Completed
Phase
Study type
Observational
Enrollment
41 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
Female
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) are common for women. Low-level laser therapy (LLLT) was applied for wound healing, but there was no study regarding treatment effect of GSM and SUI. This retrospective study aims to assess the efficacy of LLLT in alleviating GSM and SUI.

Detailed description

Between September 2022 and August 2023, all women who received LLLT for GSM and SUI at the gynecologic outpatient clinic of a hospital were retrospectively reviewed. The treatment was once a week for eight weeks. Vaginal health index (VHI) and questionnaires before and after treatment for evaluation of lower urinary tract symptoms (LUTS) and quality of life are the outcome assessment.

Conditions

Interventions

TypeNameDescription
DEVICELow-level laser therapyThe treatment was once a week for eight weeks. The patient was in a supine position. The gain medium of the laser was Gallium-Aluminum-Arsenide. The laser was introduced into vagina via a silicon vaginal probe inserted by a doctor for 30 minutes (wavelength 660nm, power density 18.17mW/cm2, energy density 0.018J/cm2s, total energy density 32.4J/cm2).

Timeline

Start date
2022-09-30
Primary completion
2023-08-14
Completion
2023-08-14
First posted
2023-11-18
Last updated
2023-11-18

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06136975. Inclusion in this directory is not an endorsement.